Best GLP-1 Online Programs (2026)

Summary: There is no single best GLP-1 online program. Manufacturer-direct routes like NovoCare and LillyDirect are cheapest for brand drugs; Henry Meds and Mochi compete on compounded access; Sequence and Calibrate sell coaching.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

There is no single best GLP-1 online program. There are roughly four categories of program, and the right one for you depends on whether you want brand-name medication through insurance, brand-name medication cash-pay, compounded medication cash-pay, or a coaching-heavy program that treats the drug as one piece of a longer plan.

This page covers eleven of the programs people ask about most. Pricing, what each one prescribes, how they handle insurance, the level of ongoing support, and the patient each one actually fits. Pricing reflects what providers publish in May 2026 and shifts often. Confirm the current number on each company's own page before signing up.

The four categories first

Picking a program starts with picking a category. The categories matter more than the brand names.

The 2024 to 2025 shortage period reshaped this market. The FDA declared the semaglutide and tirzepatide shortages resolved in early 2025, and in April 2026 proposed removing both drugs plus liraglutide from the 503B bulks list ^[3]. That means large-scale compounding is contracting. Many telehealth programs that built their business on compounded drug have pivoted to brand-name partnerships or smaller 503A compounding. The category you sign up for today may not be the category you are in six months from now.

NovoCare Pharmacy (Wegovy direct from Novo Nordisk)

NovoCare Pharmacy is Novo Nordisk's direct-to-patient channel for Wegovy. You complete a telehealth visit through a Novo Nordisk partner, receive a prescription if eligible, and the medication ships from a Novo Nordisk-affiliated pharmacy ^[1].

• Pricing: $499 per month for all Wegovy doses on cash-pay self-pay, when you skip insurance entirely. With commercial insurance and a savings card, eligible patients pay as little as $0 to $225 per month, depending on coverage.
• Prescribes: Wegovy (semaglutide) only. No compounded options. No tirzepatide.
• Insurance: Yes, but routed through your own plan. The cash-pay $499 channel is for people whose insurance does not cover Wegovy or who do not want to go through prior authorization.
• Support: Minimal. The telehealth piece is a single intake visit and refill check-ins. There is no built-in dietitian or coaching layer.
• Ideal patient: Adults with a BMI of 30 or higher (or 27 with a comorbidity) who want authentic Wegovy at a predictable monthly price and do not need a coaching wrapper.

This is the simplest, most regulatorily clean way to get Wegovy. The trade-off is that it is one drug from one manufacturer, and the support level is bare-bones.

LillyDirect (Zepbound and Mounjaro direct from Eli Lilly)

LillyDirect is Eli Lilly's parallel program. Self-Pay channel sells Zepbound single-dose vials direct to patients at a flat monthly price ^[2].

• Pricing: $349 per month for the 2.5 mg vial, $499 per month for 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg vials. Pens are sold through traditional pharmacy channels and cost more.
• Prescribes: Zepbound (tirzepatide) for weight loss; the LillyDirect site also routes Mounjaro for type 2 diabetes through a separate flow.
• Insurance: Self-Pay is cash-only, no insurance billing. You can still use FSA or HSA dollars.
• Support: Lilly partners with Form Health for the clinical visits if you do not have your own doctor. Form Health adds a registered dietitian and ongoing follow-up, but as a separate paid service.
• Ideal patient: People who want authentic Zepbound at the lowest cash-pay price the manufacturer offers, are willing to inject from a vial with a separate syringe, and do not need a high-touch program.

The vial-only Self-Pay channel is the lowest-cost legitimate tirzepatide access in the country. Pen users will pay more, often through traditional pharmacies with manufacturer savings cards.

Ro Body Program

Ro is one of the original general-purpose telehealth companies. The Ro Body Program is its weight loss product.

• Pricing: $135 per month for the membership, plus medication. Medication cost varies based on whether you use insurance for brand-name drugs or buy compounded semaglutide cash-pay.
• Prescribes: Ozempic, Wegovy, Mounjaro, Zepbound through insurance, plus compounded semaglutide and compounded tirzepatide. Ro publishes that it works with multiple compounding pharmacies and discloses which one fills each prescription.
• Insurance: Yes. Ro has a dedicated insurance support team that submits prior authorizations and follows them through to approval or denial ^[4]. This is one of Ro's main selling points.
• Support: Mid-touch. Unlimited messaging with a clinician, side-effect management, dose adjustments, and a body composition tracking app. No dietitian by default.
• Ideal patient: People with decent commercial insurance who want a polished app, insurance concierge help, and the option to switch between brand and compounded medication.

Hims and Hers Weight Loss

Hims (for men) and Hers (for women) are sister brands under the same parent company. Their weight loss programs are nearly identical in clinical model.

• Pricing: $149 to $325 per month for compounded semaglutide, depending on dose ^[4]. Brand-name medications run $299 to $1,999 per month, depending on the drug and whether insurance applies.
• Prescribes: Compounded semaglutide (oral and injectable), liraglutide, plus brand-name Mounjaro, Ozempic, Wegovy, and Zepbound.
• Insurance: Yes for brand-name drugs. The compounded semaglutide track is cash-only.
• Support: Light. The Hers and Hims model is built around a fast async intake, a prescription, and messaging-based follow-up. Dietitians and behavioral coaches are not included by default.
• Ideal patient: People who want a recognizable brand with broad medication options, want it fast, and do not need an intensive coaching program.

The compounded semaglutide pricing at Hers and Hims is competitive but not the cheapest. The reason to pick this program over a smaller compounding-only competitor is the option to transition to a brand drug later through the same account.

Henry Meds

Henry Meds built its name on flat-rate compounded GLP-1 access during the 2023 to 2024 boom.

• Pricing: Approximately $297 per month all-in for compounded semaglutide. Compounded tirzepatide runs higher, in the $400 to $500 range. The membership and medication are bundled.
• Prescribes: Compounded semaglutide and compounded tirzepatide only. No brand-name medication.
• Insurance: No. Cash-pay only.
• Support: Minimal. Clinician messaging for dose adjustments, no dietitian, no coaching.
• Ideal patient: Self-directed adults who already understand GLP-1 therapy, want compounded medication at a predictable monthly price, and do not need hand-holding.

Henry's risk in 2026 is regulatory. The FDA's proposed removal of semaglutide and tirzepatide from the 503B bulks list squeezes large-scale compounders, and Henry's supply has historically come from 503B sources ^[3]. If your Henry refill suddenly switches pharmacies, ask which one.

Found

Found markets itself as a holistic weight care program built around a physician care team.

• Pricing: Around $99 to $149 per month for the Found program fee, with medication billed separately. Brand-name medication can run through insurance; compounded options are cash-pay.
• Prescribes: Compounded semaglutide and tirzepatide, plus brand-name GLP-1s when insurance covers them. Found also prescribes off-label adjuncts like metformin, naltrexone-bupropion, and topiramate for patients who do not qualify for or tolerate GLP-1s.
• Insurance: Yes for brand drugs and for the medical visit fees, depending on plan. Compounded track is cash-pay.
• Support: Higher than average. Found includes metabolic testing at intake, a care team led by an obesity-medicine physician, and behavior change coaching ^[4]. The program requires a 12-month commitment at sign-up.
• Ideal patient: People who want a structured, longer-term program with broader pharmacology options, not just GLP-1 monotherapy, and who are willing to commit for a year.

The 12-month commitment is the catch. If you cancel early, there is a fee. Read the cancellation terms before signing.

Mochi Health

Mochi is one of the larger insurance-forward telehealth platforms.

• Pricing: $79 per month membership for compounded options up to $199 per month, depending on plan. Brand-name medication pricing varies by dose and pharmacy ^[4].
• Prescribes: Compounded oral and injectable semaglutide, compounded injectable tirzepatide, plus brand-name Mounjaro, Ozempic, Rybelsus, Saxenda, Trulicity, Victoza, Wegovy (pill and injection), and Zepbound.
• Insurance: Yes, and this is Mochi's strongest feature. The platform runs prior authorizations and uses an AI tool to predict approval probability before submission, which speeds up the process.
• Support: Mid-touch. Video visits with a clinician, unlimited messaging, dose management. Some plans include nutrition support.
• Ideal patient: People with commercial insurance who want help navigating prior authorization for brand-name GLP-1s, and who want the option to fall back to compounded medication if their insurance denies coverage.

Mochi's wide drug list is a real advantage. If your insurance only covers one of the older GLP-1s (Victoza, Trulicity), most cash-pay-focused programs will not prescribe it. Mochi will.

Sequence (WeightWatchers Clinic)

Sequence was acquired by WeightWatchers in 2023 and rebranded as WeightWatchers Clinic, though many people still call it Sequence.

• Pricing: $99 per month for the WeightWatchers Clinic membership, which includes the medical visits and the standard WeightWatchers Points program. Medication is billed separately and is mostly run through insurance.
• Prescribes: Brand-name Wegovy, Zepbound, Mounjaro, Ozempic, plus the older GLP-1s.
• Insurance: Yes. WeightWatchers Clinic is one of the most insurance-focused programs in the market. The clinical team submits prior authorizations and follows them through.
• Support: High. The membership wraps the GLP-1 prescription inside the broader WeightWatchers behavioral program. Members get medical visits, the Points system, food tracking, and group support content.
• Ideal patient: People who want brand-name medication through insurance plus a structured behavior-change program, and who do not want to coordinate the medical and behavioral pieces separately.

This is the highest-support option for people who specifically want brand-name medication. The trade-off is that if your insurance denies Wegovy or Zepbound, Sequence does not have the same compounded fallback that Ro, Hers, or Mochi do.

Future Health

Future Health (sometimes listed as Fountain in older reviews) is a newer entrant that positions itself as a broader telehealth wellness platform with GLP-1 as one product.

• Pricing: Roughly $199 to $299 per month for the GLP-1 program. Compounded semaglutide and tirzepatide are the main offerings.
• Prescribes: Compounded semaglutide, compounded tirzepatide. Brand-name access is limited.
• Insurance: No. Cash-pay only for the GLP-1 line.
• Support: Light to mid-touch. Clinician messaging and dose management. Some plans bundle hormone testing or other wellness add-ons.
• Ideal patient: Existing customers of the platform's hormone or wellness products who want to add GLP-1 access to an existing account, not standalone weight-loss patients.

If you are evaluating Future Health purely for GLP-1, you are likely paying for features (hormone testing, peptide therapy, lab panels) you will not use.

Push Health

Push Health is a different model. It is a platform for licensed clinicians to run their own micro-practices, not a vertically integrated telehealth company.

• Pricing: Varies by the clinician. Most Push Health providers charge $50 to $100 for a visit and write a prescription you fill at a compounding pharmacy of your choice or theirs. Total monthly cost depends on the pharmacy.
• Prescribes: Whatever the clinician prescribes. Most Push Health clinicians who advertise GLP-1 services write for compounded semaglutide or compounded tirzepatide.
• Insurance: No. Cash-pay only.
• Support: Variable. Depends entirely on the individual clinician. Some are responsive and structured; others are bare-bones script-writers.
• Ideal patient: Cost-sensitive patients who already have a relationship with a Push Health clinician, or who want flexibility on which pharmacy fills their prescription.

Push Health is the closest thing to "old-school" telehealth: a doctor, a prescription, you pick where to fill it. The lack of standardization means quality is uneven. Vet the clinician before paying.

Calibrate

Calibrate is the highest-touch coaching program in this list.

• Pricing: Around $199 per month for the coaching and medical layer, plus medication billed separately through insurance or cash. The full annual commitment runs $1,600+ depending on plan.
• Prescribes: Brand-name GLP-1s when insurance covers, falling back to off-label and adjunct medications when it does not. Calibrate does not lean heavily on compounded GLP-1s.
• Insurance: Yes. The team handles prior authorization.
• Support: High. Calibrate's model is built around a one-year curriculum with monthly coaching calls, weekly content, sleep and stress tracking, food logging, and a coach who is a registered dietitian or health coach.
• Ideal patient: People who view the medication as one tool in a longer behavior-change program, who have insurance for brand-name GLP-1s, and who are willing to pay for a structured coaching layer on top.

Calibrate's pitch is that medication alone produces less durable weight loss than medication plus structured behavior change. The research broadly supports that, but the price premium is real.

A framework for choosing

Stop comparing brand names. Start by answering four questions in order.

1. Does your insurance cover Wegovy or Zepbound for weight loss? Many plans still exclude weight-loss drugs even when they cover the diabetes versions. Check your plan's formulary before anything else. If yes, you want a program with strong insurance handling: Ro, Mochi, WeightWatchers Clinic, or Calibrate.

2. If insurance is not an option, do you want brand-name or compounded medication? Brand-name cash-pay means manufacturer-direct: NovoCare for Wegovy at $499 per month, LillyDirect for Zepbound vials at $349 to $499. These are the cheapest legitimate routes to brand medication. Compounded is cheaper still ($129 to $399) but comes with the caveat that compounded GLP-1s are not FDA-approved and the regulatory environment is tightening ^[3].

3. How much coaching do you want? Henry Meds and Push Health give you almost none. Hers and Hims give you light async support. Ro and Mochi sit in the middle. Found, Sequence, and Calibrate are built around structured programs with dietitians, coaches, and content.

4. How long are you willing to commit? Most programs are month-to-month. Found requires 12 months. Calibrate prices its program annually. The longer commitments tend to come with more support and a higher total spend.

How to evaluate any program before signing up

A few questions to ask before you put a card down, regardless of which program you are looking at.

• Which pharmacy fills the prescription, and is it accredited by the Pharmacy Compounding Accreditation Board (PCAB) or the National Association of Boards of Pharmacy (NABP)? Reputable compounders will publish this and provide a Certificate of Analysis for the medication on request ^[4].
• Does the program use video visits or only an async questionnaire? Async is faster but offers less clinical judgment. Mixed models tend to be safer for first-time GLP-1 users.
• Are labs included, and is bloodwork repeated at six months? Comprehensive metabolic panel, A1C, and a thyroid panel are the standard baseline. Programs that never order labs are cutting a corner that matters.
• What is the cancellation policy? Multi-month or annual commitments should be in writing. If the cancellation terms are not on the public site, ask before signing.
• How does the program handle a brand drug shortage? After the 2024 to 2025 shortage period, the answer to this question separates well-run programs from improvised ones.

What this article does not rank

This page is not a leaderboard. The market is large and changes monthly, and the FDA's 503B decision in mid-2026 will reshape who can offer what. Forbes Health's review of affordable providers, US News Health's 15-provider comparison, and the recent rankings on Medbound Times and GLP1 Watchdog all reach different "top picks" because they weight criteria differently ^[4][5]. Use them as cross-references, not as gospel.

Common questions about choosing a GLP-1 program

What is the best GLP-1 online program with coaching?

Calibrate has the most structured one-year coaching curriculum. WeightWatchers Clinic (Sequence) is a close second and is the most affordable coaching-led option at $99 per month plus medication.

What is the best GLP-1 with coaching for under $200 per month total?

WeightWatchers Clinic at $99 per month membership plus an insurance-covered brand-name GLP-1 fits this budget if your insurance approves Wegovy or Zepbound.

Are the top GLP-1 providers in 2026 the same as in 2025?

No. The FDA's removal of semaglutide and tirzepatide from the 503B bulks list reshaped the compounded side of the market in early 2026. NovoCare and LillyDirect, both manufacturer-direct programs, grew significantly because they bypass the compounding question entirely.

How do I find the best GLP-1 provider by state?

All eleven programs in this article ship to all 50 states. State-by-state availability mostly matters for older or smaller telehealth companies. Check the program's "service area" page before signing.

What are GLP-1 providers reviews actually measuring?

Most public reviews measure onboarding speed, app polish, and customer service responsiveness. They rarely measure clinical outcomes (weight loss at 6 and 12 months, side-effect resolution rates) because programs do not publish that data uniformly.

How do I compare GLP-1 programs without getting lost?

Use the four-question framework: insurance yes or no, brand or compounded, coaching level, commitment length. Once you have your four answers, only two or three programs in this list will fit, and the comparison becomes manageable.

What are the benefits of switching GLP-1 providers?

Lower price, better insurance handling, or a different medication option. The main risk is a gap in supply during the switch. Time your transition so the new program has approved your prescription and shipped before your current vial runs out.

How do I switch GLP-1 providers without losing dose continuity?

Sign up with the new program two to three weeks before your current refill runs out. Tell the new clinician your current dose, current pharmacy, and last injection date. Ask them to write the next prescription at your current maintenance dose, not at the starting dose, so you do not regress.

Is there a GLP-1 medication availability tracker?

The FDA Drug Shortages database is the official source. Several telehealth-watching sites publish unofficial availability dashboards, but the FDA list is the only one with regulatory weight. The semaglutide and tirzepatide shortages closed in early 2025.

Do GLP-1 programs work in rural areas?

Yes. The whole point of telehealth GLP-1 access is that it works anywhere with mail delivery and a video-capable phone. Rural patients often benefit most because local obesity-medicine specialists are scarce.

What does GLP-1 access equity look like in 2026?

Cash-pay programs starting at $129 to $179 per month have narrowed the affordability gap compared to retail brand-name pricing of $1,000+ per month, but the cheapest options are still compounded and unevenly regulated. Manufacturer-direct programs at $349 to $499 are the most equity-positive brand-drug option because the price is the same regardless of zip code or employer plan.

How big is the GLP-1 market in 2026?

GLP-1 prescribing has grown roughly tenfold since 2021, with US revenue from Wegovy, Zepbound, Ozempic, and Mounjaro now exceeding $40 billion annually. The telehealth share of that has grown faster than the in-clinic share.

What this article does not cover

Pricing changes constantly. The numbers above reflect what each company publishes in May 2026, and several of these programs adjust monthly. Insurance coverage is even more variable; two patients with the same employer can have different formulary tiers depending on hire date. Check the program's own pricing page and your own insurance plan before signing. For a deeper look at how compounded medication regulation is shifting, see the FDA's pages on the 503A and 503B pharmacy distinctions and the May 2026 503B bulks list decision.